Gu B - Search Results

1

Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial.

Cai C, Zhang X, Sun X, Wang H, Chen E, Chen L, Gu B, Wang J, Huang X, Lao W, Wang X, Chen M, Ding S, Du J, Song Z. Cai C, et al. Among authors: gu b. BMC Cancer. 2024 Oct 9;24(1):1247. doi: 10.1186/s12885-024-12994-0. BMC Cancer. 2024. PMID: 39385104 Free PMC article. Clinical Trial.

2

Effect of intensity modulated radiotherapy combined with s-1-based chemotherapy in locally advanced gastric cancer patients.

Hu JB, Sun XN, Gu BX, Wang Q, Hu WX. Hu JB, et al. Oncol Res Treat. 2014;37(1-2):11-6. doi: 10.1159/000358164. Epub 2014 Jan 24. Oncol Res Treat. 2014. PMID: 24613903

3

An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma.

Qian L, Lai X, Gu B, Sun X. Qian L, et al. Among authors: gu b. Front Immunol. 2022 May 6;13:784479. doi: 10.3389/fimmu.2022.784479. eCollection 2022. Front Immunol. 2022. PMID: 35603163 Free PMC article.

4

Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy.

Shan J, Gu B, Shi L, Wang X, Ye W, Zhou W, Sun X. Shan J, et al. Among authors: gu b. Transl Cancer Res. 2021 Jan;10(1):88-98. doi: 10.21037/tcr-20-2269. Transl Cancer Res. 2021. PMID: 35116242 Free PMC article.

5

Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy.

Sun XN, Wang Q, Gu BX, Zhu YH, Hu JB, Shi GZ, Zheng S. Sun XN, et al. World J Gastroenterol. 2011 Jan 21;17(3):397-402. doi: 10.3748/wjg.v17.i3.397. World J Gastroenterol. 2011. PMID: 21253402 Free PMC article.

6

Concurrent Chemoradiotherapy in Curatively Resected Gallbladder Carcinoma: A Propensity Score-Matched Analysis.

Gu B, Qian L, Yu H, Hu J, Wang Q, Shan J, Shi L, Liu H, Yang Q, Liang X, Cai X, Sun X. Gu B, et al. Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):138-145. doi: 10.1016/j.ijrobp.2017.09.029. Epub 2017 Sep 20. Int J Radiat Oncol Biol Phys. 2018. PMID: 29066119

7

Inflammation index predicts radiation-induced lung injury and prognosis in lung tumors treated with stereotactic body radiation therapy.

Shan J, Xie X, Gu B, Sun X, Liu H. Shan J, et al. Among authors: gu b. Jpn J Radiol. 2024 Jan;42(1):102-108. doi: 10.1007/s11604-023-01482-3. Epub 2023 Sep 9. Jpn J Radiol. 2024. PMID: 37684513

8

A feedback constraint optimization method for intensity-modulated radiation therapy of nasopharyngeal carcinoma.

Li Y, Sun X, Wang QI, Zhou Q, Gu B, Shi G, Jiang D. Li Y, et al. Among authors: gu b. Oncol Lett. 2015 Oct;10(4):2043-2050. doi: 10.3892/ol.2015.3523. Epub 2015 Jul 23. Oncol Lett. 2015. PMID: 26622793 Free PMC article.

9

Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma.

Sun XN, Cao WG, Wang X, Wang Q, Gu BX, Yang QC, Hu JB, Liu H, Zheng S. Sun XN, et al. Tumour Biol. 2011 Dec;32(6):1183-90. doi: 10.1007/s13277-011-0221-2. Epub 2011 Aug 19. Tumour Biol. 2011. PMID: 21853312

10

HDAC inhibitors reverse acquired radio resistance of KYSE-150R esophageal carcinoma cells by modulating Bmi-1 expression.

Dong Q, Sharma S, Liu H, Chen L, Gu B, Sun X, Wang G. Dong Q, et al. Among authors: gu b. Toxicol Lett. 2014 Jan 3;224(1):121-9. Toxicol Lett. 2014. PMID: 24459703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,446 results

Search Page

Filters